[Relapse in anxiety disorders].

Terugval bij angststoornissen.

Journal

Nederlands tijdschrift voor geneeskunde
ISSN: 1876-8784
Titre abrégé: Ned Tijdschr Geneeskd
Pays: Netherlands
ID NLM: 0400770

Informations de publication

Date de publication:
15 02 2019
Historique:
entrez: 1 3 2019
pubmed: 1 3 2019
medline: 1 9 2020
Statut: epublish

Résumé

Because the risk of relapse is high in anxiety disorders, it is important to bear in mind long-term prospects when making treatment decisions. This means that patients may need 'booster' treatment or continuous antidepressant medication to achieve long-term positive outcomes. Preparing a patient for a possible relapse in the end phase of a successful treatment, especially when there is a desire to discontinue the use of antidepressants, or timely intervention in case of an actual relapse episode is crucial to prevent recurrence of the anxiety disorder.

Identifiants

pubmed: 30816655
pii:

Substances chimiques

Antidepressive Agents 0

Types de publication

Journal Article

Langues

dut

Sous-ensembles de citation

IM

Auteurs

Anna D T Muntingh (ADT)

Amsterdam UMC, locatie VUmc, afd. Psychiatrie.
Contact: A.D.T. Muntingh (a.muntingh@ggzingeest.nl).

Neeltje M Batelaan (NM)

Amsterdam UMC, locatie VUmc, afd. Psychiatrie.

Anton J L M van Balkom (AJLM)

Amsterdam UMC, locatie VUmc, afd. Psychiatrie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH